TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease.

[1]  S. Liddelow,et al.  Neuroinflammatory astrocyte subtypes in the mouse brain , 2021, Nature Neuroscience.

[2]  D. Geschwind,et al.  Ageing-associated myelin dysfunction drives amyloid deposition in mouse models of Alzheimer’s disease , 2021, bioRxiv.

[3]  J. Chan,et al.  Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer’s disease , 2021, Neuron.

[4]  L. Buée,et al.  THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency , 2021, Neurobiology of Disease.

[5]  Kathleen M. Jagodnik,et al.  Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.

[6]  Melanie A. Huntley,et al.  Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology , 2021, Neuron.

[7]  F. Quintana,et al.  Microglia and Central Nervous System-Associated Macrophages-From Origin to Disease Modulation. , 2021, Annual review of immunology.

[8]  Markus M. Hilscher,et al.  Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury , 2020, Nature Communications.

[9]  C. Haass,et al.  Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease , 2020, Neuron.

[10]  P. Matthews,et al.  Single-Nucleus RNA-Seq Is Not Suitable for Detection of Microglial Activation Genes in Humans , 2020, Cell reports.

[11]  Joakim Lundeberg,et al.  Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease , 2020, Cell.

[12]  Ulrich Dirnagl,et al.  The ARRIVE guidelines 2.0: updated guidelines for reporting animal research , 2020, The Journal of physiology.

[13]  Melanie A. Huntley,et al.  Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation , 2020, Cell reports.

[14]  I. Amit,et al.  The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway , 2020, Cell.

[15]  Jamie L. Marshall,et al.  Disease-associated astrocytes in Alzheimer’s disease and aging , 2020, Nature Neuroscience.

[16]  K. Scearce-Levie,et al.  Leveraging preclinical models for the development of Alzheimer disease therapeutics , 2020, Nature Reviews Drug Discovery.

[17]  Aviv Regev,et al.  Systematic comparison of single-cell and single-nucleus RNA-sequencing methods , 2020, Nature Biotechnology.

[18]  F. Ginhoux,et al.  Early Fate Defines Microglia and Non-parenchymal Brain Macrophage Development , 2020, Cell.

[19]  J. Grinspan.  Inhibitors of Myelination and Remyelination, Bone Morphogenetic Proteins, are Upregulated in Human Neurological Disease , 2020, Neurochemical Research.

[20]  J. Elstrott,et al.  Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model , 2020, The Journal of Neuroscience.

[21]  L. Buée,et al.  Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology , 2020, EMBO molecular medicine.

[22]  Mark M. Davis,et al.  Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease , 2020, Nature.

[23]  Christopher J. Bohlen,et al.  Microglia in Brain Development, Homeostasis, and Neurodegeneration. , 2019, Annual review of genetics.

[24]  Maxim N. Artyomov,et al.  Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and - independent cellular responses in Alzheimer’s disease , 2019, Nature Medicine.

[25]  Z. Modrušan,et al.  Heterogeneity of satellite cells implicates DELTA1/NOTCH2 signaling in self-renewal , 2019, bioRxiv.

[26]  A. Butt,et al.  Oligodendroglial Cells in Alzheimer's Disease. , 2019, Advances in experimental medicine and biology.

[27]  D. Holtzman,et al.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.

[28]  B. Becher,et al.  The CNS Immune Landscape from the Viewpoint of a T Cell , 2019, Trends in Neurosciences.

[29]  Gary D. Bader,et al.  Single-cell transcriptomic profiling of the aging mouse brain , 2019, Nature Neuroscience.

[30]  Kyle A. Martin,et al.  Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination , 2019, Nature Communications.

[31]  F. C. Bennett,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[32]  Mark M. Davis,et al.  Single cell analysis reveals T cell infiltration in old neurogenic niches , 2019, Nature.

[33]  Richard Reynolds,et al.  Neuronal vulnerability and multilineage diversity in multiple sclerosis , 2019, Nature.

[34]  E. Tartour,et al.  Editorial: Tissue Resident Memory T Cells , 2019, Front. Immunol..

[35]  Virginia M. Y. Lee,et al.  TREM2 function impedes tau seeding in neuritic plaques , 2019, Nature Neuroscience.

[36]  Y. Saeys,et al.  A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment , 2019, Nature Neuroscience.

[37]  D. Masopust,et al.  Tissue-Resident T Cells and Other Resident Leukocytes. , 2019, Annual review of immunology.

[38]  Dheeraj Malhotra,et al.  Altered human oligodendrocyte heterogeneity in multiple sclerosis , 2019, Nature.

[39]  Bradley T. Hyman,et al.  Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis , 2019, Nature Reviews Neuroscience.

[40]  F. Quintana,et al.  Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation , 2019, Cell.

[41]  J. Trojanowski,et al.  Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review , 2019, JAMA neurology.

[42]  G. Castelo-Branco,et al.  Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis , 2018, Nature Medicine.

[43]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[44]  G. Coppola,et al.  Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy , 2018, Proceedings of the National Academy of Sciences.

[45]  L. Bodea,et al.  Rodent models for Alzheimer disease , 2018, Nature Reviews Neuroscience.

[46]  Xiaokun Li,et al.  FGF Family: From Drug Development to Clinical Application , 2018, International journal of molecular sciences.

[47]  Joseph R. Scarpa,et al.  Epigenetic regulation of brain region-specific microglia clearance activity , 2018, Nature Neuroscience.

[48]  F. C. Bennett,et al.  A Combination of Ontogeny and CNS Environment Establishes Microglial Identity , 2018, Neuron.

[49]  Kristel Sleegers,et al.  Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics. , 2018, Trends in genetics : TIG.

[50]  J. Delgado-García,et al.  R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System , 2018, The Journal of Neuroscience.

[51]  Z. Mari,et al.  Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease , 2018, Nature Medicine.

[52]  Eyal David,et al.  Re-evaluating Microglia Expression Profiles Using RiboTag and Cell Isolation Strategies , 2018, Nature Immunology.

[53]  Lars E. Borm,et al.  Molecular Architecture of the Mouse Nervous System , 2018, Cell.

[54]  James E. Goldman,et al.  White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes , 2018, Acta Neuropathologica Communications.

[55]  J. Hanson,et al.  Microglia in Alzheimer’s disease , 2018, The Journal of cell biology.

[56]  Melanie A. Huntley,et al.  Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse Models. , 2018, Cell reports.

[57]  Bin Zhang,et al.  Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation , 2017, Nature Medicine.

[58]  Allon M. Klein,et al.  Single-Cell Analysis of Experience-Dependent Transcriptomic States in Mouse Visual Cortex , 2017, Nature Neuroscience.

[59]  R. Ransohoff,et al.  TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy , 2017, Molecular Neurodegeneration.

[60]  D. Holtzman,et al.  TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy , 2017, Proceedings of the National Academy of Sciences.

[61]  A. Fagan,et al.  ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy , 2017, Nature.

[62]  Markus Glatzel,et al.  The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. , 2017, Immunity.

[63]  Maxim N. Artyomov,et al.  TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease , 2017, Cell.

[64]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[65]  David V. Hansen,et al.  TREM2, Microglia, and Neurodegenerative Diseases. , 2017, Trends in molecular medicine.

[66]  S. Mallal,et al.  T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.

[67]  A. Ishii,et al.  Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2–MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner , 2017, The Journal of Neuroscience.

[68]  Aaron T. L. Lun,et al.  Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R , 2017, Bioinform..

[69]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[70]  John C Marioni,et al.  A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor , 2016, F1000Research.

[71]  Jens Hjerling-Leffler,et al.  Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system , 2016, Science.

[72]  J. Grutzendler,et al.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy , 2016, Neuron.

[73]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[74]  S. Linnarsson,et al.  Origin, fate and dynamics of macrophages at central nervous system interfaces , 2016, Nature Immunology.

[75]  D. Holtzman,et al.  TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.

[76]  Benjamin E. L. Lauffer,et al.  Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses , 2016, Nature Communications.

[77]  D. Lodygin,et al.  Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid , 2016, Nature.

[78]  Giulio Genovese,et al.  Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.

[79]  R. Guerreiro,et al.  The age factor in Alzheimer’s disease , 2015, Genome Medicine.

[80]  M. Colonna,et al.  TREM2 sustains microglial expansion during aging and response to demyelination. , 2015, The Journal of clinical investigation.

[81]  David E. Strochlic,et al.  The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase , 2015, Nature Medicine.

[82]  D. Holtzman,et al.  TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.

[83]  M. Yaylaoglu,et al.  A Death Receptor 6-Amyloid Precursor Protein Pathway Regulates Synapse Density in the Mature CNS But Does Not Contribute to Alzheimer's Disease-Related Pathophysiology in Murine Models , 2014, The Journal of Neuroscience.

[84]  Christina Müller,et al.  Making myelin basic protein -from mRNA transport to localized translation , 2013, Front. Cell. Neurosci..

[85]  Robert H Miller.  Signaling pathways that regulate glial development and early migration—oligodendrocytes , 2013, Patterning and Cell Type Specification in the Developing CNS and PNS.

[86]  Avi Ma'ayan,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[87]  G. Smyth,et al.  The Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated from the Brain , 2012, The Journal of Immunology.

[88]  A. Cardona,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[89]  B. Barres,et al.  Genomic Analysis of Reactive Astrogliosis , 2012, The Journal of Neuroscience.

[90]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[91]  L. Ozmen,et al.  Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice , 2010, Neurobiology of Disease.

[92]  S. Di Giovanni,et al.  The non‐apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon , 2009, EMBO reports.

[93]  L. Ozmen,et al.  Expression of Transgenic APP mRNA Is the Key Determinant for Beta-Amyloid Deposition in PS2APP Transgenic Mice , 2008, Neurodegenerative Diseases.

[94]  J. Kemp,et al.  PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation , 2003, The Journal of Neuroscience.

[95]  R. Nitsch,et al.  Tau Filament Formation in Transgenic Mice Expressing P301L Tau* , 2001, The Journal of Biological Chemistry.

[96]  D L Price,et al.  A vector for expressing foreign genes in the brains and hearts of transgenic mice. , 1996, Genetic analysis : biomolecular engineering.

[97]  A. Aguzzi,et al.  Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie. , 1996, The EMBO journal.